Status: Recruiting
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
Assessment of the utility of family-based (trio) whole-genome sequencing for cancer predisposition testing in sequential newly diagnosed paediatric and adolescent cancer patients
Participants needed: 270
Trial details
Age: Up to 21Biological sex: AllType: ObservationalSponsor: Sydney Children's Hospitals NetworkUpdated: Nov 4, 2022Locations: 3
Eligibility criteria
New diagnosis of malignancy [+5]